A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of CS0159 in Subjects With NASH

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
A randomized, double-blind study to assess the safety, tolerability, PK and efficacy of CS0159 in subjects with Non-Alcoholic Steatohepatitis (NASH)
Epistemonikos ID: 9464fe9cd4e35651e18eea2eb6f63a57ff9cb67a
First added on: May 14, 2024